Suppression of human macrophage-mediated cytotoxicity by transgenic swine endothelial cell expression of HLA-G

Transplant Immunology

Volumn 32, Issue 2, 2015, Pages 109-115

  Esquivel, Emilio L ^a   Maeda, Akira ^a   Eguchi, Hiroshi ^a   Asada, Mayumi ^a   Sugiyama, Miku ^a   Manabe, Chieko ^a   Sakai, Rieko ^a   Matsuura, Rei ^a   Nakahata, Kengo ^a   Okuyama, Hiroomi ^a   Miyagawa, Shuji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

HLA G1; ILT2; ILT4; KIR2DL4; Macrophage; Xenotransplantation

Indexed keywords

BETA 2 MICROGLOBULIN; COMPLEMENTARY DNA; CYTOKINE; HLA G ANTIGEN; HLA G1 ANTIGEN; IMMUNOGLOBULIN LIKE TRANSCRIPT 2 PROTEIN; IMMUNOGLOBULIN LIKE TRANSCRIPT 4 PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GRAFT REJECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SWINE; TRANSGENE; TRANSGENIC ANIMAL; ANIMAL; CELLULAR IMMUNITY; COCULTURE; FEMALE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; MALE; PATHOLOGY; PIG;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION; HLA-G ANTIGENS; HUMANS; IMMUNITY, CELLULAR; MACROPHAGES; MALE; SWINE;

EID: 84926408903     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2014.12.004     Document Type: Article

References (25)

1. Miyagawa S., Hirose H., Shirakura R., Naka Y., Nakata S., Kawashima Y., et al. The mechanism of discordant xenograft rejection. Transplantation 1988, 46:825-830.
2. Miyagawa S., Yamamoto A., Matsunami K., Wang D., Takama Y., Ueno T., et al. Complement regulation in the GalT KO era. Xenotransplantation 2010, 17:11-25.
3. Ekser B., Rigotti P., Gridelli B., Cooper D.K. Xenotransplantation of solid organs in the pig-to-primate model. Transpl Immunol 2009, 21:87-92.
4. Mohiuddin M.M., Singh A.K., Corcoran P.C., Hoyt R.F., Thomas M.L., Ayares D., et al. Genetically engineered pigs and target-specific immunomodulation provide significant graft survival and hope for clinical cardiac xenotransplantation. J Thorac Cardiovasc Surg 2014, 148:1106-1113.
5. Matsunami K., Miyagawa S., Nakai R., Murase A., Shirakura R. The possible use of HLA-G1 and G3 in the inhibition of NK cell-mediated swine endothelial cell lysis. Clin Exp Immunol 2001, 126:165-172.
6. Matsunami K., Miyagawa S., Nakai R., Yamada M., Shirakura R. Modulation of the leader peptide sequence of the HLA-E gene up-regulates its expression and dowanregulates natural killer cell-mediated swine endothelial cell lysis. Transplantation 2002, 73:1582-1589.
7. Miyagawa S., Nakai R., Matsunami K., Kusama T., Shirakura R. Co-effect of HLA-G1 and glycosyltransferases in reducing NK cell-mediated pig endothelial cell lysis. Transpl Immunol 2003, 11:147-153.
8. Maeda A., Kawamura T., Ueno T., Usui N., Eguchi H., Miyagawa S. The suppression of inflammatory macrophage-mediated cytotoxicity and proinflammatory cytokine production by transgenic expression of HLA-E. Transpl Immunol 2013, 29:76-81.
9. Miyagawa S., Shirakura R., Iwata K., Nakata S., Matsumiya G., Izutani H., et al. Effects of transfected complement regulatory proteins, MCP, DAF, MCP/DAF hybrid, on complement-mediated swine endothelial cell lysis. Transplantation 1994, 58:834-840.
10. Matsunami K., Kusama T., Okura E., Shirakura R., Fukuzawa M., Miyagawa S. Involvement of position-147 for HLA-E expression. Biochem Biophys Res Commun 2006, 347:692-697.
11. Apps R., Gardner L., Sharkey A.M., Holmes N., Moffett A. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur J Immunol 2007, 37:1924-1937.
12. Shiroishi M., Kuroki K., Rasubala L., Tsumoto K., Kumagai I., Kurimoto E., et al. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc Natl Acad Sci U S A 2006, 103:16412-16417.
13. Shiroishi M., Tsumoto K., Amano K., Shirakihara Y., Colonna M., Braud V.M., et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci U S A 2003, 100:8856-8861.
14. Kovats S., Main E.K., Librach C., Stubblebine M., Fisher S.J., DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990, 248:220-223.
15. Ishitani A., Geraghty D.E. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci U S A 1992, 89:3947-3951.
16. McMaster M.T., Librach C.L., Zhou Y., Lim E.H., Janatpour M.J., DeMars R., et al. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol 1995, 154:3771-3778.
17. Howangyin K.Y., Loustau M., Wu J., Alegre E., Daouya M., Caumartin J., et al. Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors. Cell Mol Life Sci 2012, 69:4041-4049.
18. LeMaoult J., Daouya M., Wu J., Loustau M., Horuzsko A., Carosella E.D. Synthetic HLA-G proteins for therapeutic use in transplantation. FASEB J 2013, 27:3643-3651.
19. Naji A., Rouas-Freiss N., Durrbach A., Carosella E.D., Sensébé L., Deschaseaux F. Concise review: combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy. Stem Cells 2013, 31:2296-2303.
20. Braud V.M., Allan D.S., O'Callaghan C.A., Roncador G., Braud V.M., Mason D.Y., et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998, 391:795-799.
21. Ide K., Wang H., Tahara H., Liu J., Wang X., Asahara T., et al. Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages. Proc Natl Acad Sci U S A 2007, 104:5062-5066.
22. Weiss E.H., Lilienfeld, Mueller S., Mueller E., Herbach N., Kessler B., et al. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity. Transplantation 2009, 87:35-43.
23. Pazmany L., Mandelboim O., Vales G.M., Davis D.M., Reyburn H.T., Strominger J.L. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 1996, 274:792-795.
24. Rouas F.N., Marchal R.E., Kirszenbaum M., Dausset J., Carosella E.D. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?. Proc Natl Acad Sci U S A 1997, 94:5249-5254.
25. Sasaki H., Xu X.C., Smith D.M., Howard T., Mohanakumar T. HLA-G expression protects porcine endothelial cells against natural killer cell-mediated xenogenic cytotoxicity. Transplantation 1999, 67:31-37.